Taro Pharmaceutical
TARO
#5182
Rank
A$2.43 B
Marketcap
A$64.92
Share price
0.00%
Change (1 day)
5.41%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): A$1.82

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is A$1.84. an increase over its 2022 EPS that were of A$1.84.

EPS history for Taro Pharmaceutical from 2011 to 2023

Annual EPS

Year EPS Change
2023A$1.840%
2022A$1.842950%
2021A$0.06043-100.51%
2020A-$11.95-222.45%
2019A$9.76-18.02%
2018A$11.9153.01%
2017A$7.78-55.95%
2016A$17.66-13.41%
2015A$20.4036.92%
2014A$14.9037.71%
2013A$10.8221.15%
2012A$8.9344.15%
2011A$6.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.09 447.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.93 330.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.07-41.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.50-18.60%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.35 135.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.68-63.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel